FDA On Celebrex: Use Low Dose, If At All

FDA is advising physicians to consider alternative therapies and lowest effective dose. During a teleconference, FDA’s Crawford says Celebrex and COX-2s may be appropriate for patients who need favorable GI profile compared to older NSAIDs, despite celecoxib product warning on NSAID GI toxicity.